a2 Milk Company Ltd.

Citi Analyst Maintains Buy Rating on a2 Milk

Citibank downgrades A2 Milk to neutral

A2 BIO's First Patient Receives A2B395 Dosing

FirstCape Group Limited Acquires 5.003% Stake in a2 Milk Company Ltd

New Zealand's S&P/NZX 50 index fell 0.3% to 13,257, marking its lowest close since late September, influenced by declines in AI stocks and anticipation of US inflation data. The economy grew 1.1% in Q3, surpassing expectations. Notable stock decliners included Fisher & Paykel, Infratil, a2 Milk, and Air New Zealand, while Meridian Energy, Fletcher Building, Ryman Healthcare, and Argosy Property saw gains.

Trading Economics

New Zealand Stocks Extend Drop

The order comes from Nexty Electronics and relates to Acconeer’s first product in the A2 family, the A212 Pulsed Coherent Radar sensor. The order is intended for mass production in the automotive industry and will be used by a European premium car manufacturer for several in-cabin use cases. Delivery planned to be completed in July 2026.CEO Ted Hansson comments: “We are pleased to receive another order, confirming customer demand and volume ramp up.”

Modular Finance Ab

Acconeer receives USD 260 000 order from Nexty Electronics

New Zealand's S&P/NZX 50 index rose 0.1% to 13,425, with notable gains from Meridian Energy, A2 Milk, Delegat Group, Spark, and Ventia Group. However, these were nearly offset by losses from Third Age, Gentrack, Hallenstein Glasson, and Tourism Holdings. Traders anticipate key data releases, including Q3 GDP. New Zealand's annual food inflation eased to 4.4% in November, and the government's budget update showed a larger deficit, with no surplus expected in the next five years.

NZ Shares Close Slightly Higher

Citi analyst Sam Teeger maintains a Buy rating for a2 Milk Company with a price target of A$10.45. Teeger, a 3-star analyst with a 1.7% average return, covers the Consumer Cyclical sector. The general analyst consensus for a2 Milk Company is a Moderate Buy with a $6.57 average price target.

Tip Ranks

Citi Sticks to Its Buy Rating for a2 Milk Company (ACOPF)

a2 Milk Company Limited announced a change in director David Landt Bortolussi's interest. As of December 8, 2025, he acquired 324,606 performance rights under the company's Long Term Incentive Plan. This move aligns leadership interests with long-term strategic goals, potentially impacting investor confidence and market perception.

a2 Milk Company Announces Director’s Change in Interest

a2 Milk Company Limited announced the issuance of 324,606 performance rights to employees as part of an incentive scheme. These rights are not intended to be quoted on the ASX, aiming to align employee interests with company performance and enhance operational efficiency and stakeholder value.

a2 Milk Company Issues Performance Rights to Employees

New Zealand's S&P/NZX 50 index rose 0.6% to 13,582, driven by gains in utilities, healthcare, and consumer non-durables. The market was buoyed by positive Wall Street trends and expectations of a US Federal Reserve interest rate cut. Comments from RBNZ Governor Anna Breman on prioritizing low inflation and economic growth also boosted sentiment. Key gainers included Fisher & Paykel Healthcare, Meridian Energy, and a2 Milk. Property stocks like Precinct Properties and Kiwi Property also performed well.

New Zealand Stocks Rise for Second Day

a2 Milk Company has received regulatory approvals from New Zealand and China, marking a key milestone for expanding its infant milk formula products in China. The company projects low double-digit growth in FY26, despite facing margin pressures. The regulatory progress is crucial for long-term growth but doesn't immediately address short-term margin risks. Investors should consider potential delays in China market approvals and competition. The company's narrative forecasts NZ$2.2 billion revenue and NZ$280.4 million earnings by 2028, requiring 5.4% annual revenue growth.

Simplywall

Does China’s Regulatory Green Light Change the Bull Case for a2 Milk (NZSE:ATM)?

New Zealand Shares Rise Ahead of US Fed Rate Decision; a2 Milk Co. Secures Regulatory Approvals to Progress China-Label Formula

marketscreener

New Zealand Shares Rise Ahead of US Fed Rate Decision; a2 Milk Co. Secures Regulatory Approvals to Progress China-Label Formula

A2 Milk Company Ltd :UPDATE ON A2 POKENO REGULATORY APPROVAL PROCESSRECEIVES APPROVAL FROM MINISTRY FOR PRIMARY INDUSTRIES AND GENERAL ADMINISTRATION OF CHINA CUSTOMSFINAL STEP IS SAMR APPROVAL APPLICATION IN DECEMBER 2025APPROVAL ON PROCESS TO ACHIEVE CHINA REGULATORY APPROVAL TO TRANSITION TWO CHINA LABEL INFANT MILK FORMULA PRODUCT REGISTRATIONS

Reuters

A2 Milk Updates On A2 Pokeno Regulatory Approval Process

COST

New Zealand's NZX 50 index fell by 49 points (0.4%) to 13,371, driven by declines in consumer staples, financials, and healthcare sectors. Traders are cautious ahead of the RBNZ's monetary policy decision, with expectations of a 25 bps rate cut. Economic data releases are also anticipated. Despite losses, Wall Street's positive session limited the decline. Notable early losers included A2 Milk, Mainfreight, and Contact Energy. Kiwi Property reported a 77% drop in net profit for the six months ended September.

Target

Costco Wholesale

Kroger

New Zealand Stocks Slip at Start of the Week

Morgan Stanley analyst Julia de Sterke maintains a Buy rating on a2 Milk Company with a price target of A$10.00. Citi also keeps a Buy rating with a target of A$9.29. De Sterke has an average return of -2.8% and a 33.33% success rate. TipRanks offers a Black Friday sale on its Premium insights and research tools.

Morgan Stanley Keeps Their Buy Rating on a2 Milk Company (ACOPF)

Morningstar has upgraded its EBITDA guidance for a2 Milk by 3% to NZ$312 million for FY26, aligning with the company's forecast of low-double-digit revenue growth. Despite this, Morningstar considers the upgrade immaterial to its fair value estimate of NZ$8, citing rising costs and a challenging Chinese market. The firm's shares are deemed expensive, having risen 69.8% this year.

Outlook upgrade for NZ's a2 Milk 'immaterial' to valuation, Morningstar says

A2 Gold Corp. has identified high-priority drill targets at its Eastside Project in Nevada after completing geophysical surveys. The surveys revealed a larger potential mineralized system, particularly along a 5 km hydrothermal alteration anomaly and a 62 sq km pediment shelf. The company plans to start road construction in December 2025 and begin a major RC drill program in January 2026. The drilling aims to support an updated NI-43-101 resource estimate in early 2026.